Novocure Ltd (NASDAQ:NVCR)
| 153.02 Delayed Data As of 3:59pm ET |  +0.67 / +0.44%Today’s Change | 53.40 Today|||52-Week Range 194.75 | -11.57% Year-to-Date |
Latest NVCR News | Press Releases
| Better Buy: iShares Russell 2000 Growth ETF vs Schwab U.S. Small-Cap ETF Feb 28 / MotleyFool.com - Paid Partner Content | NovoCure (NVCR) Q4 Earnings and Revenues Miss Estimates Feb 25 / Zacks.com - Paid Partner Content |
| NovoCure (NVCR) Q4 2020 Earnings Call Transcript Feb 25 / MotleyFool.com - Paid Partner Content | Why Earnings Season Could Be Great for NovoCure (NVCR) Feb 24 / Zacks.com - Paid Partner Content |
| Why NovoCure Stock Sank Today Feb 25 / MotleyFool.com - Paid Partner Content | NovoCure (NVCR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Feb 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 152.35 |
| Today’s open | 142.02 |
| Day’s range | 149.56 - 153.94 |
| Volume | 28,003 |
| Average volume (3 months) | 986,456 |
| Market cap | $15.3B |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +16.67% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +40.72% |
| P/E ratio | 850.1 |
| Price/Sales | 38.11 |
| Price/Book | 32.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | +0.19 | +0.11% |
| MASIMasimo Corp | -5.00 | -1.95% |
| TNDMTandem Diabetes Care... | -2.05 | -2.14% |
| NVRONevro Corp | -1.55 | -0.91% |
Data as of 4:00pm ET, 03/02/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $494.4M |
| Annual profit (last year) | $19.8M |
| Net profit margin | 4.01% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters St. Helier, Jersey |
Forecasts
